ID

22602

Description

Terms of use: You may not use this document or the information contained herein to a regulatory authority in connection with an application for a marketing authorization or any other regulatory submission without the express written consent of Roche Study #: FVF4168g Drug: Ranibizumab Study Title: A Phase III, Double-Masked, Multicenter, Randomized, Sham-Controlled Study Of The Efficacy And Safety Of Ranibizumab Injection In Subjects With Clinically Significant Macular Edema With Center Involvement Secondary To Diabetes Mellitus

Mots-clés

  1. 08/06/2017 08/06/2017 -
Détendeur de droits

Genentech, Inc.

Téléchargé le

8 juin 2017

DOI

Pour une demande vous connecter.

Licence

Creative Commons BY-NC 3.0

Modèle Commentaires :

Ici, vous pouvez faire des commentaires sur le modèle. À partir des bulles de texte, vous pouvez laisser des commentaires spécifiques sur les groupes Item et les Item.

Groupe Item commentaires pour :

Item commentaires pour :

Vous devez être connecté pour pouvoir télécharger des formulaires. Veuillez vous connecter ou s’inscrire gratuitement.

GENERAL MEDICAL HISTORY AND BASELINE CONDITIONS (SCREENING) CRFs Roche FVF4168G Macular Edema NCT00473330

GENERAL MEDICAL HISTORY AND BASELINE CONDITIONS (SCREENING) CRFs Roche FVF4168G Macular Edema NCT00473330

Patient administration
Description

Patient administration

Subject Number
Description

PT

Type de données

integer

Alias
UMLS CUI [1]
C2348585
Subject Initials:
Description

PTINIT

Type de données

text

Alias
UMLS CUI [1,1]
C1997894
UMLS CUI [1,2]
C2986440
Report Date:
Description

VDT

Type de données

date

Alias
UMLS CUI [1,1]
C1302584
GENERAL MEDICAL HISTORY AND BASELINE CONDITIONS (SCREENING)
Description

GENERAL MEDICAL HISTORY AND BASELINE CONDITIONS (SCREENING)

Does the subject have any other medical history or baseline conditions, not specified on a Targeted Medical History CRF?
Description

If Yes, record each diagnosis and its status below. Do not record diagnoses / physical findings already captured on the Targeted Medical History CRF. The following Systems / Categories should be reviewed by the investigator: Neurologic / Psychiatric • Gastrointestinal • Endocrine • Ophthalmologic • Genitourinary / Reproductive • Hematologic • Ears, Nose, Throat • Musculoskeletal • Allergies / Drug Sensitivities • Cardiovascular • Dermatologic • Malignancy • Respiratory

Type de données

boolean

Alias
UMLS CUI [1]
C0262926
Other Medical History
Description

Other Medical History

Line Number
Description

LINE_NUMBER [LN]

Type de données

integer

Alias
UMLS CUI [1,1]
C0449788
UMLS CUI [1,2]
C0087111
Diagnosis
Description

MED_HX_DESCRIPTION [HXDES]

Type de données

text

Alias
UMLS CUI [1]
C0011900
Condition Currently Active?
Description

MED_HX_ACTIVE [HXACT]

Type de données

boolean

Alias
UMLS CUI [1]
C2707252
Onset Date
Description

MED_HX_DT [HXDT]

Type de données

boolean

Alias
UMLS CUI [1,1]
C0574845
UMLS CUI [1,2]
C0439673

Similar models

GENERAL MEDICAL HISTORY AND BASELINE CONDITIONS (SCREENING) CRFs Roche FVF4168G Macular Edema NCT00473330

Name
Type
Description | Question | Decode (Coded Value)
Type de données
Alias
Item Group
Patient administration
PT
Item
Subject Number
integer
C2348585 (UMLS CUI [1])
PTINIT
Item
Subject Initials:
text
C1997894 (UMLS CUI [1,1])
C2986440 (UMLS CUI [1,2])
VDT
Item
Report Date:
date
C1302584 (UMLS CUI [1,1])
Item Group
GENERAL MEDICAL HISTORY AND BASELINE CONDITIONS (SCREENING)
MED_HX_RECORDS
Item
Does the subject have any other medical history or baseline conditions, not specified on a Targeted Medical History CRF?
boolean
C0262926 (UMLS CUI [1])
Item Group
Other Medical History
LINE_NUMBER [LN]
Item
Line Number
integer
C0449788 (UMLS CUI [1,1])
C0087111 (UMLS CUI [1,2])
MED_HX_DESCRIPTION [HXDES]
Item
Diagnosis
text
C0011900 (UMLS CUI [1])
MED_HX_ACTIVE [HXACT]
Item
Condition Currently Active?
boolean
C2707252 (UMLS CUI [1])
MED_HX_DT [HXDT]
Item
Onset Date
boolean
C0574845 (UMLS CUI [1,1])
C0439673 (UMLS CUI [1,2])

Utilisez ce formulaire pour les retours, les questions et les améliorations suggérées.

Les champs marqués d’un * sont obligatoires.

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial